---
title: LYVA Labs - Investment Fund
description: Pre-seed investment to grow your innovative health and life science, deep tech, or clean tech business in Liverpool City Region.
---

[![logo](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/logo.svg "logo")](https://lyvalabs.com/?hsLang=en)

- About 
    - [Our purpose](https://lyvalabs.com/about)
    - [Case studies](https://lyvalabs.com/case-studies)
    - [Team](https://lyvalabs.com/team)
    - [News](https://lyvalabs.com/news)
    - [Annual Report](https://lyvalabs.com/annualreport25-26)
- [Investment](https://lyvalabs.com/investment-fund)
- Programmes 
    - [Adapt](https://lyvalabs.com/adapt)
    - [Incubator](https://lyvalabs.com/incubator)
    - [Accelerate](https://lyvalabs.com/accelerate)
- Services 
    - [Consortia](https://lyvalabs.com/consortia)
- Work with Us 
    - [Careers](https://lyvalabs.com/vacancies)
    - [Consultants](https://lyvalabs.com/lyva-labs-expert-partner-opportunities)

[![logo](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/logo.svg "logo")](https://lyvalabs.com/?hsLang=en)

- About 
    - [Our purpose](https://lyvalabs.com/about)
    - [Case studies](https://lyvalabs.com/case-studies)
    - [Team](https://lyvalabs.com/team)
    - [News](https://lyvalabs.com/news)
    - [Annual Report](https://lyvalabs.com/annualreport25-26)
- [Investment](https://lyvalabs.com/investment-fund)
- Programmes 
    - [Adapt](https://lyvalabs.com/adapt)
    - [Incubator](https://lyvalabs.com/incubator)
    - [Accelerate](https://lyvalabs.com/accelerate)
- Services 
    - [Consortia](https://lyvalabs.com/consortia)
- Work with Us 
    - [Careers](https://lyvalabs.com/vacancies)
    - [Consultants](https://lyvalabs.com/lyva-labs-expert-partner-opportunities)

[Contact Us](https://lyvalabs.com/contact?hsLang=en)

[Contact Us](https://lyvalabs.com/contact?hsLang=en)

# Investment to grow your innovative health and life science, deep tech, or clean tech business

As part of the Liverpool City Region’s vision to increase the impact of the health and life science and deep tech sectors, Liverpool City Region Combined Authority has provided LYVA Labs with £7m for pre-seed investment to accelerate growth, create jobs, and address the funding gap for early stage start-ups in the region.

 

Innovative businesses and start-ups across the region can apply for investment of £10,000 to £250,000 for idea development and commercialisation. 

 

As managers of the fund, we aim to create an ecosystem of high-growth companies. Any returns on investments made go back into this Challenge Fund to allow continued innovation for businesses within the region.

## Our investment focus areas

![](https://lyvalabs.com/hs-fs/hubfs/Incubator/2.png?width=300&height=300&name=2.png)

Health & Life Science

![1](https://lyvalabs.com/hs-fs/hubfs/Incubator/1.png?width=300&height=300&name=1.png "1")

Clean Tech

![](https://lyvalabs.com/hs-fs/hubfs/Incubator/3.png?width=300&height=300&name=3.png)

Deep Tech

---

### Who is this for?

Start-up or early stage business innovating in the health and life science, clean tech, and deep tech sectors.

 

Businesses must be based or willing to relocate to Liverpool City Region.

 

LYVA Labs will also consider co-investment in a larger round alongside other investors.

 

This fund is not suitable for those working in pharma, drugs, alcohol, or consumer health industries.

 

---

### Looking for tailored support alongside investment?

![Incubator Assets  2026-3](https://lyvalabs.com/hs-fs/hubfs/Incubator%20Assets%20%202026-3.png?width=800&height=400&name=Incubator%20Assets%20%202026-3.png "Incubator Assets  2026-3")

**Now open to new applications**

 

[Learn more](https://lyvalabs.com/incubator?hsLang=en)

### How we support your investment journey

###### Helping you get investment ready

If you fit our eligibility and our team think the idea is innovative with great potential, we will work with you to identify the best mechanism of support which may be through our [incubator](https://lyvalabs.com/incubator?hsLang=en) programme, [accelerate](https://lyvalabs.com/accelerate?hsLang=en) programme or writing a investment proposal that we will pitch to our investment committee.

We can help your business at all stages, from setting up a company, to developing your business case and conducting market research and competitor analysis.

If we decide not to invest in your company we can still provide connections, business support and commercialisation advice to develop your business.

###### Working with you to grow

If the investment is approved, or you join our incubator, you will become a part of our portfolio companies. Depending on circumstances, we may appoint a NED and our team will work with you to track progress and be on-hand to provide ongoing support such as grant applications, connecting with our tech development and research partners, and with introductions to the next round of investors.

###### We're an Innovate UK Investor Partner

The IUK Investor Partnership programme is a unique grant opportunity aligned to equity investment for high-growth, innovative UK companies to access the funding they need to thrive and succeed. Learn more [here](https://iuk.ktn-uk.org/programme/investor-partnerships-future-economy/).

### Our investment approach

![](https://lyvalabs.com/hs-fs/hubfs/Investment%20Approach.jpg?width=1000&height=258&name=Investment%20Approach.jpg)

> ## "LYVA Labs has helped us connect to the right people. We would like to thank Liverpool City Region Combined Authority, the LYVA Labs team, and Lorna Green personally for her vision in setting up the company."
> 
> 
> 
> ![](https://lyvalabs.com/hs-fs/hubfs/Investment%20Images/Jennet%20Beasley%20-%20DP.jpg?width=150&height=150&name=Jennet%20Beasley%20-%20DP.jpg)
> 
>  Dr Jennet Beasley, Founder, Daresbury Proteins

> ## "Investment from LYVA Labs will allow the company to complete the development of autoICSI and associated AI based high-definition vision camera system in record time. Ensuring the system is ready for full clinical trial and regulatory approval."
> 
> 
> 
> ![](https://lyvalabs.com/hs-fs/hubfs/Investment%20Images/Yash%20Khandia.jpg?width=150&height=150&name=Yash%20Khandia.jpg)
> 
>  Dr Yash Khandia, CEO, Myma Medical

# Interested?

[Contact the team](https://lyvalabs.com/contact?hsLang=en)

 Investment Portfolio

- All
- Health & Life Science
- Deep Tech

[![](https://lyvalabs.com/hubfs/Case%20Studies/Daresbury%20Proteins/Daresbury%20Proteins%20Website%20Case%20Study%20Thumbnail.png)](https://lyvalabs.com/news/daresbury-proteins-investment?hsLang=en)

## Daresbury Proteins

 Production of difficult to express proteins and cell line development

[Learn more](https://lyvalabs.com/news/daresbury-proteins-investment?hsLang=en)

[![](https://lyvalabs.com/hubfs/Case%20Studies/Myma%20Medical/Myma%20Medical%20Website%20Case%20Study%20Thumbnail.png)](https://lyvalabs.com/news/myma-medical-investment?hsLang=en)

## Myma Medical

 Automating the ICSI process for IVF clinics

[Learn more](https://lyvalabs.com/news/myma-medical-investment?hsLang=en)

[![](https://lyvalabs.com/hubfs/Case%20Studies/Entropix/Entropix%20Spotlight.png)](https://lyvalabs.com/news/state-of-the-art-enzyme-development-company-entropix-secures-investment-from-lyva-labs?hsLang=en)

## Entropix

 Developing novel enzymes and biocatalysts

[Learn more](https://lyvalabs.com/news/state-of-the-art-enzyme-development-company-entropix-secures-investment-from-lyva-labs?hsLang=en)

[![](https://lyvalabs.com/hubfs/Case%20Studies/Spotlight%20Pathology/Spotlight%20Pathology%20Spotlight.png)](https://lyvalabs.com/news/spotlight-pathology-investment?hsLang=en)

## Spotlight Pathology

 A.I. decision support tools for blood cancer diagnosis

[Learn more](https://lyvalabs.com/news/spotlight-pathology-investment?hsLang=en)

[![](https://lyvalabs.com/hubfs/Case%20Studies/Pellitec/Pellitec%20Tectores%20Spotlight.png)](https://lyvalabs.com/news/lyva-labs-invests-50000-in-wirral-based-health-innovators-tectores?hsLang=en)

## Tectores

 Pellitec, blister prevention pads for footwear

[Learn more](https://lyvalabs.com/news/lyva-labs-invests-50000-in-wirral-based-health-innovators-tectores?hsLang=en)

[![](https://lyvalabs.com/hubfs/Case%20Studies/BBL%20Protect/BBL%20Spotlight.jpg)](https://lyvalabs.com/news/lyva-labs-makes-largest-investment-into-innovation-businesses-in-one-month?hsLang=en)

## BBL Protect

 Solutions for safe patient transfer and isolation

[Learn more](https://lyvalabs.com/news/lyva-labs-makes-largest-investment-into-innovation-businesses-in-one-month?hsLang=en)

[![](https://lyvalabs.com/hubfs/Case%20Studies/Haptiv8/Haptiv8%20Spotlight.jpg)](https://lyvalabs.com/news/lyva-labs-makes-largest-investment-into-innovation-businesses-in-one-month?hsLang=en)

## Haptiv8

 Wearable technology solutions to aid tiptoe walkers

[Learn more](https://lyvalabs.com/news/lyva-labs-makes-largest-investment-into-innovation-businesses-in-one-month?hsLang=en)

[![](https://lyvalabs.com/hubfs/Case%20Studies/VizBox/Vizbox%20Spotlight.jpg)](https://lyvalabs.com/news/lyva-labs-makes-largest-investment-into-innovation-businesses-in-one-month?hsLang=en)

## Vizbox

 Virtual reality solutions to aid with neuro-rehabilitation recovery

[Learn more](https://lyvalabs.com/news/lyva-labs-makes-largest-investment-into-innovation-businesses-in-one-month?hsLang=en)

[![](https://lyvalabs.com/hubfs/Case%20Studies/CCI%20Photonics/CCI%20Photonics%20Spotlight.jpg)](https://lyvalabs.com/news/lyva-labs-invests-100k-into-a-med-tech-device-that-detects-bacteria-in-urinary-tract-infections?hsLang=en)

## CCI Photonics

 Identification of infectious diseases in 15 minutes

[Learn more](https://lyvalabs.com/news/lyva-labs-invests-100k-into-a-med-tech-device-that-detects-bacteria-in-urinary-tract-infections?hsLang=en)

[![](https://lyvalabs.com/hubfs/medco%20-%20Case%20Study.jpg)](https://medcotec.com/)

## MedCo Tec

 Engineering design and project management for the medical and pharmaceutical sector.

[Learn more](https://medcotec.com/)

[![Ocuwell - Case Study](https://lyvalabs.com/hubfs/Ocuwell%20-%20Case%20Study.jpg)](https://lyvalabs.com/news/lyva-labs-invests-in-ocuwell?hsLang=en)

## Ocuwell

 Portable, cloud-enabled corneal diagnostics and treatment customisation tools.

[Learn more](https://lyvalabs.com/news/lyva-labs-invests-in-ocuwell?hsLang=en)

[![](https://lyvalabs.com/hubfs/GutSee%20Health%20-%20Case%20Study.jpg)](https://gutseehealth.com/)

## GutSee Health

 Precision microbiome and phage therapies for chronic gut disorders.

[Learn more](https://gutseehealth.com/)

[![](https://lyvalabs.com/hubfs/Plasma%20Fresh%20-%20Case%20Study-1.jpg)](https://lyvalabs.com/news/lyva-labs-joins-1m-seed-round-for-university-of-liverpool-spin-out-plasma-fresh?hsLang=en)

## Plasma Fresh

 Cold plasma technology delivering sustainable, continuous-cleaning solutions for food processing.

[Learn more](https://lyvalabs.com/news/lyva-labs-joins-1m-seed-round-for-university-of-liverpool-spin-out-plasma-fresh?hsLang=en)

[![](https://lyvalabs.com/hubfs/Refold.png)](https://www.linkedin.com/company/refold-therapeutics/)

## Refold Therapeutics

 Therapies targeting misfolded light-chain diseases, initially focusing on light-chain amyloidosis.

[Learn more](https://www.linkedin.com/company/refold-therapeutics/)

![](https://lyvalabs.com/hubfs/Heatio/Heatio%20Spotlight.png)

## Heatio

 Home energy data and analytics platform for adoption of low carbon technologies

 Learn more

[![](https://lyvalabs.com/hubfs/Case%20Studies/Birl/2.jpg)](https://lyvalabs.com/incubator-cohort2-2024-25?hsLang=en)

## Birl

 No-touch resales solution for fashion retailers and sports brands

[Learn more](https://lyvalabs.com/incubator-cohort2-2024-25?hsLang=en)

[![](https://lyvalabs.com/hubfs/Case%20Studies/Gigmate/4.jpg)](https://lyvalabs.com/incubator-cohort2-2024-25?hsLang=en)

## Gigmate

 Platform connecting fans, gigs, bands and venues

[Learn more](https://lyvalabs.com/incubator-cohort2-2024-25?hsLang=en)

[![](https://lyvalabs.com/hubfs/Case%20Studies/Universal%20Atmosphere%20Processing/3.jpg)](https://lyvalabs.com/incubator-cohort2-2024-25?hsLang=en)

## Universal Atmosphere Processing

 GHG capture and noble gas production

[Learn more](https://lyvalabs.com/incubator-cohort2-2024-25?hsLang=en)

[![](https://lyvalabs.com/hubfs/Case%20Studies/Atomik%20AM/Atomik%20Spotlight.jpg)](https://lyvalabs.com/news/lyva-labs-invests-125k-in-atomik-am-to-develop-binder-jet-solutions-for-additive-manufacturing?hsLang=en)

## Atomik AM

 Binder jet solutions for additive manufacturing

[Learn more](https://lyvalabs.com/news/lyva-labs-invests-125k-in-atomik-am-to-develop-binder-jet-solutions-for-additive-manufacturing?hsLang=en)

[![](https://lyvalabs.com/hubfs/sense%20ai%20-%20Case%20Study.jpg)](https://lyvalabs.com/news/lyva-labs-backs-university-of-liverpool-spin-out-senseai-in-seed-investment-round-led-by-foresight?hsLang=en)

## SenseAI Vision

 Fast, low-dose subsampling and imaging for electron microscopy.

[Learn more](https://lyvalabs.com/news/lyva-labs-backs-university-of-liverpool-spin-out-senseai-in-seed-investment-round-led-by-foresight?hsLang=en)

[![](https://lyvalabs.com/hubfs/sum%20vivas%20-%20Case%20Study.jpg)](https://www.sumvivas.com/)

## Sum Vivas

 AI-powered digital humans transforming customer engagement through natural, human-like interaction.

[Learn more](https://www.sumvivas.com/)

[Our recent investment announcements](https://lyvalabs.com/news?hsLang=en)

[![logo-light](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/logo-light.svg "logo-light")](https://lyvalabs.com/?hsLang=en)

- [![location](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/location.svg) Central Tech, 31 Russell St, Liverpool, L3 5LJ ![](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/link.svg)](https://maps.app.goo.gl/2UkwzwAXMeanwV4s9)
- ![mail](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/mail.svg) enquiries@lyvalabs.com ![](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/link.svg)
- [![linkedin](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/linkedin.svg) LinkedIn ![](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/link.svg)](https://www.linkedin.com/company/lyvalabs/)

About Us

- [Our purpose](https://lyvalabs.com/about?hsLang=en)
- [News](https://lyvalabs.com/news?hsLang=en)
- [Case studies](https://lyvalabs.com/case-studies?hsLang=en)

Programmes

- [Incubator](https://lyvalabs.com/incubator?hsLang=en)
- [Accelerate](https://lyvalabs.com/accelerate?hsLang=en)
- [Adapt](https://lyvalabs.com/adapt-waitlist?hsLang=en)

Services

- [Investment](https://lyvalabs.com/investment-fund)
- [Consortia](https://lyvalabs.com/consortia?hsLang=en)

Keep up to date with LYVA Labs by subscribing to our newsletter.

© 2026 LCR Ventures trading as LYVA Labs. All rights reserved.

- Terms & Conditions
- [Privacy Policy](https://lyvalabs.com/privacy-policy?hsLang=en)